Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial.

Affiliation

Collaborators: Janssens W, Vos R, Gyselinck I, Vanderhelst E, Bouckaert B, Alexander P, De Mayer N, Papleux E, Soenen AC, Derweduwe A, Vandeurzen K, Martinot JB, Goeminne P, Nguyen H, Pilette C, Schildermans R, Decoster L.
Author information:
(1)Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium. [Email]
(2)Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
(3)Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Leuven, Belgium.

Abstract

Erratum in Trials. 2021 Mar 5;22(1):187.